SDEE’s Investor Day with Illumina Ventures January 18th

Apply for SDEE’s Investor Day with Illumina Ventures

The deadline to apply has been extended to Thursday, January 4, 2018

Pitch Your Healthcare Startup and Network with Other CEOs/Founders

Submissions due by January 2, 2018

Event Sponsor:

Wouter Meuleman, Ph.D. Director, Venture Investments

Noel Jee, Ph.D., Investment Associate

Illumina Ventures invests in early-stage companies that are pioneering new applications of genomics and enabling precision medicine – including life science tools, clinical diagnostics, and therapeutic platforms.

Our limited partners include Illumina, the world's leading genomics solutions provider, as well as global corporate, institutional, sovereign, and individual investors.

Our team members have spent decades at the forefront of genomics innovation and share a passion for improving human health.

To be considered for this event, please submit a single page executive summary, or non-confidential slide deck (less than 25 slides) by January 4, 2018 via email to: [email protected]

You will be notified by January 12 if your company has been selected for a 1:1 meeting. ALL APPLICANTS are invited and encouraged to attend the networking breakfast and introduction & discussion with Illumina Ventures. The event is only open to SDEE members.

(Join here: http://www.sdentrepreneurs.org/join_sdee)

Wouter Meuleman is Director at Illumina Ventures, and was previously Illumina, Inc. where he worked in a variety of leadership roles throughout the organization, including R&D, Product Development, and Corporate Development. A physical chemist by training, he began his career in life sciences as first employee at Oxford University spin-out Oxamer, a company founded in 2003 by Lasker award winner Prof. Sir Edwin Southern, where he led the development a benchtop DNA microarray fabrication platform. Following the company’s incorporation into Oxford Gene Technology in 2005, he continued working alongside Prof. Southern leading R&D programs in areas such as single cell gene expression analysis and novel applications for DNA microarrays. He obtained his undergraduate and Master’s degree in Chemistry from the University of Ghent, Belgium; a PhD in Chemical Engineering from the University of Newcastle, U.K; and an MBA from the University of Cambridge, U.K.

Noel Jee is an Investment Associate at Illumina Ventures. Prior to joining the fund, Noel worked at L.E.K. Consulting as a management consultant specializing in the life sciences. He has consulted on strategy engagements for companies in the pharmaceuticals, biotech, and diagnostics industries. Before joining L.E.K. Consulting, Noel helped to co-found and bootstrap the San Francisco-based medical device and digital health startup Knox Medical Diagnostics, where he led the initial business development. He obtained dual BS degrees from the University of Maryland College Park, and his PhD in Chemistry and Chemical Biology from the University of California San Francisco.